Delivery Order SPE2DB22D9239-SPE2DB24FDL77
Award Date
8/16/24
Potential Completion Date
9/9/24
Potential Value
$65K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,614.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of BOTOX. This order is placed under DMS Pharmaceutical Group's existing indefinite-delivery, indefinite-quantity (IDIQ) contract SPE2DB, valued at up to $4,999,999 through 2025, which allows DLA to issue delivery orders for a broad range of pharmaceutical products to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4,562,472,907 units of BOTOX 200 unit vials. The contract, which has an ultimate completion date of November 3, 2023, has a ceiling value of $15,524.40. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB22D9362 with DLA, which allows the agency to order a broad range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
The Defense Logistics Agency (DLA) awarded a $5,537.76 firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 100-unit vials of BOTOX. This delivery order falls under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which enables the DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $8,306.64 firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of Botox. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract 4600082013 between DMS Pharmaceutical Group and DLA, valued up to $4,999,999 through 2025. The IDV enables DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,762.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 200-unit vials of BOTOX to support the recurring medical supply needs of military health facilities. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of the drug Botox. The contract, valued at $5,537.76, has a firm fixed-price pricing type and a completion date of April 9, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA valued up to $4,999,999 through 2025, which allows DLA to place delivery orders for a wide range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $46,148.00, is for the delivery of 100-unit vials of the drug Botox with a completion date of May 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, that allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 200 unit vials of BOTOX. The order, valued at $3,881.10, will be fulfilled by the completion date of February 16, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, with DLA valued up to $4,999,999 through 2025 for a broad range of pharmaceutical items to support...